ROBERT S BREUIL
CIK 1241009 · Chief Financial Officer · last filed 2023-03-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$34.5K
Companies
3
Total Filings
25
Lifetime Open-Market Net
-$12.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CALC | Chief Financial Officer | 48,003 | $0.72 | $34.5K | $0 | 1 | 2023-03-27 |
| CalciMedica, Inc. (GRAY) Delisted | Chief Financial Officer | 163,849 | $5.50 | $901.2K | -$28.6K | 17 | 2023-03-15 |
| Corium International, Inc. (CORI) Delisted | Chief Financial Officer | 0 | — | — | $16.0K | 7 | 2018-11-28 |
Recent Filings · Page 2 of 3
25 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-23 | CalciMedica, Inc. (GRAY) Delisted | Mixed | +23,460 | -$14.7K | EDGAR |
| 2022-04-04 | CalciMedica, Inc. (GRAY) Delisted | Mixed | +2,812 | -$2.7K | EDGAR |
| 2022-03-02 | CalciMedica, Inc. (GRAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-07 | CalciMedica, Inc. (GRAY) Delisted | Exer (M) | +5,000 | $0 | EDGAR |
| 2021-09-24 | CalciMedica, Inc. (GRAY) Delisted | Mixed | +12,717 | -$25.9K | EDGAR |
| 2021-05-21 | CalciMedica, Inc. (GRAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-10 | CalciMedica, Inc. (GRAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-09-28 | CalciMedica, Inc. (GRAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-28 | Corium International, Inc. (CORI) Delisted | Disp (D) | −14,441 | -$180.5K | EDGAR |
| 2018-08-17 | Corium International, Inc. (CORI) Delisted | Mixed | +1,841 | -$8.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.